In this episode, we explore the crucial aspects of patient selection for Transcranial Magnetic Stimulation (TMS) in treating depression. We discuss insurance criteria, contraindications, and practical considerations. Did you know that while TMS was FDA-approved in 2008, it wasn't widely accessible until Medicare began covering it in 2014?

Faculty: Simon Kung, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1 CME: TMS in Psychiatry: Innovations and Best Practices
• Optimizing Patient Selection for TMS Treatment